These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Quantitative bone SPECT/CT: high specificity for identification of prostate cancer bone metastases. Tabotta F, Jreige M, Schaefer N, Becce F, Prior JO, Nicod Lalonde M. BMC Musculoskelet Disord; 2019 Dec 26; 20(1):619. PubMed ID: 31878904 [Abstract] [Full Text] [Related]
5. Usefulness of quantitative bone SPECT/CT for medication-related osteonecrosis of the jaw in clinical settings. Moridera K, Kitajima K, Yoshikawa K, Takaoka K, Tsuchitani T, Noguchi K, Kishimoto H, Yamakado K. Jpn J Radiol; 2022 May 26; 40(5):492-499. PubMed ID: 34851501 [Abstract] [Full Text] [Related]
6. The value of skeletal standardized uptake values obtained by quantitative single-photon emission computed tomography-computed tomography in differential diagnosis of bone metastases. Zhang Y, Li B, Yu H, Song J, Zhou Y, Shi H. Nucl Med Commun; 2021 Jan 26; 42(1):63-67. PubMed ID: 33044406 [Abstract] [Full Text] [Related]
10. Maximum standardized uptake value from quantitative bone single-photon emission computed tomography/computed tomography in differentiating metastatic and degenerative joint disease of the spine in prostate cancer patients. Mohd Rohani MF, Mat Nawi N, Shamim SE, Wan Sohaimi WF, Wan Zainon WMN, Musarudin M, Said MA, Hashim H. Ann Nucl Med; 2020 Jan 26; 34(1):39-48. PubMed ID: 31612417 [Abstract] [Full Text] [Related]
13. Standardized uptake values of 99mTc-MDP in normal vertebrae assessed using quantitative SPECT/CT for differentiation diagnosis of benign and malignant bone lesions. Qi N, Meng Q, You Z, Chen H, Shou Y, Zhao J. BMC Med Imaging; 2021 Feb 27; 21(1):39. PubMed ID: 33639883 [Abstract] [Full Text] [Related]
14. Quantitative assessment of 99mTc-methylene diphosphonate bone SPECT/CT for assessing bone metastatic burden and its prognostic value in patients with castration-resistant prostate cancers: initial results in a single-center retrospective study. Oya T, Ichikawa Y, Nakamura S, Tomita Y, Sasaki T, Inoue T, Sakuma H. Ann Nucl Med; 2023 Jun 27; 37(6):360-370. PubMed ID: 36947324 [Abstract] [Full Text] [Related]
17. Intra- and Interobserver Agreement of SUV SPECT Quantitative SPECT/CT Processing Software, Applied in Clinical Settings for Patients with Solid Renal Tumors. Tzortzakakis A, Holstensson M, Hagel E, Karlsson M, Axelsson R. J Nucl Med Technol; 2019 Sep 27; 47(3):258-262. PubMed ID: 31019039 [Abstract] [Full Text] [Related]